Health ❯ Research ❯ Clinical Trials

Drug Development

Breakthrough Treatments Prion Disease Treatments Neuroprotective Agents Mitochondrial Medicine G Protein-Coupled Receptors Future Treatments Olorofim Trials Gene Therapy GLP-1 Receptor Agonists Lithium Compounds Future Prospects Innovative Therapies ACLY Inhibition Gerontology Personalized Medicine Nitisinone Trials Kinase Inhibitors Targeted Therapy Experimental Medications Alzheimer's Drug RI-AG03 Safety and Efficacy Aging Research Cancer Therapies

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Researchers say prior human safety testing for the drug in Parkinson’s and ALS supports moving toward trials even though how the brain clears the proteins remains unclear.

Lithium Chloride Rewires Alzheimer’s-Linked Pathways in Cell Study

UCL Analysis Finds APOE Variants Drive Most Alzheimer’s Cases

Tufts Team Designs Experimental Four-Hormone Obesity Drug Aimed at Bigger, Gentler Weight Loss

ACLY Inhibitor Triggers B Cell Response to Suppress Liver Tumors and Advances Toward Clinical Trials

UCSF Validates GPCR ADGRG1’s Role in Clearing Alzheimer’s Plaques, Paving Way for New Therapies

MLi-2 Kinase Inhibitor Fully Restores Neuronal Cilia and Promotes Recovery in a Parkinson’s Mouse Model

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials